![]() PMV Pharma PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. | ||
Founding Date | Founding Date 2011 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seongnam-si, KR HQ | Locations Cranbury Township, US HQ |
Employees | Employees 1285% increase | Employees 642% increase |
Financial | ||
Net income | Net income ₩143.2b (FY, 2024) | Net income ($77.7m) (FY, 2025) |

PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
View company